DDJ Patient Article · March 2026 · Explained in simple terms
How much does a history of gum disease increase the risk of implant complications and implant loss, and what does this mean for patient selection?
Explained in simple terms based on current scientific research. This article helps you make informed decisions together with your dentist.
This topic is about understanding how a condition might develop and what this means for your own treatment.
The key points
The most important findings at a glance:
- The results are mixed — there are both positive and cautionary findings.
- The scientific foundation is solid, but not all questions have been definitively answered.
- Risk should be presented as a range, not as a simple warning.
- It is not the gum disease diagnosis alone that determines implant risk, but whether it is controlled and the patient participates in care.
Why is this topic important for you?
You may have heard that there are different opinions on this topic. That's because science is often more complex than a simple yes-or-no answer suggests. In this article, we explain what current research actually shows — without jargon and without leaving out important details.
A history of gum disease is not an automatic reason to rule out implants, but it's also not an insignificant finding. The real question is: how large is the risk?
Why is this important for you? Because as a patient, you can make better decisions when you understand the background. This article doesn't replace a conversation with your dentist, but it gives you the knowledge to ask the right questions.
In research, the main questions center on these areas: quantifying the additional risk, treated versus untreated gum disease, and implications for patient counseling. For each of these areas, we explain what the studies show and what it means for your daily life.
What does "quantifying the additional risk" mean for me as a patient?
One of the most common questions patients ask about this topic concerns quantifying the additional risk. The answer is not as simple as one might hope — but research now provides clear guidance.
The most solid quantitative scientific evidence comes from a comprehensive review of studies by Annunziata et al. (2025), which included only prospective long-term follow-up studies lasting at least 36 months. From 13,761 initial records, 14 studies (17 articles) were selected, with eight studies rated as low risk and six as medium risk for bias using the Newcastle-Ottawa Scale. The combined analysis showed that patients with a history of gum disease (periodontitis) compared to those with healthy gums had a significantly increased risk of implant loss with a hazard ratio of 1.75.
Particularly informative are the findings on bone loss around implants: patients with a history of gum disease showed an average of 0.41 mm more bone loss. For implant-related bone infections, the odds ratio was 3.24, while for implant-related gum inflammation, no significant difference between groups was found. This distinction is clinically important: the risk mainly affects the severe form of bone-destroying disease, not mild tissue inflammation.
Ravidà et al. (2024) add a cost perspective. In their analysis of 399 adults with more than 10 years of follow-up, gum disease treatment was overall cost-effective in preventing tooth loss and implant replacement. However, active smoking completely eliminated this cost-effectiveness. Former smokers with advanced gum disease benefited most from gum disease treatment, while smoking reduced cost-effectiveness in a dose-dependent manner.
A review of multiple studies by Monje et al. (2014) focused specifically on generalized aggressive gum disease (periodontitis) (GAgP) and included six non-randomized prospective clinical studies. Survival rates were 83.3 to 100% for GAgP, 96.4 to 100% for chronic gum disease (periodontitis), and 96.9 to 100% for healthy individuals over an average period of 48 to 72 months. Although the overall risk ratio for survival was not significant (RR 0.96; 95% CI: 0.91–1.01; p = 0.14), failure rate analysis showed a fourfold increased failure rate for AgP compared to healthy individuals (RR 4.0) and compared to chronic gum disease (periodontitis) (RR 3.97). Marginal bone loss was on average 0.28 mm higher in GAgP than in healthy individuals and 0.43 mm higher than in chronic gum disease (periodontitis).
Methodologically, it should be noted that the included studies varied considerably in study design, follow-up period, and population selection. This heterogeneity limits the comparability of results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For applicability to the German-speaking healthcare context, it is additionally relevant that a substantial portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structures, treatment practices, and patient access can influence effect sizes without making the basic conclusion invalid.
For clinical practice, a hazard ratio of 1.75 for implant loss means that the risk is relevant but not prohibitive. With a baseline implant loss rate of approximately 2 to 4% over 10 years in gum-healthy populations, this rate increases to an estimated 3.5 to 7% in people with gum disease, which represents an acceptable prognosis for the majority of patients provided the periodontal condition is controlled.
The sixfold increased risk in Grade C gum disease (periodontitis) (HR 6.16), however, marks a clinically relevant risk threshold that must be explicitly addressed in patient selection and informed consent. These patients require more intensive follow-up care and transparent discussion about the limited prognosis.
In everyday practice, this means: Scientific evidence does not provide a one-size-fits-all answer, but rather a framework for individualized decisions. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must be incorporated into the decision-making process.
What does this mean for you? Risk should be presented as a spectrum, not as a binary warning.
What does this mean for your next dental visit? Research findings help you better understand your dentist's recommendations and ask specific questions if something is unclear.
Science has studied this topic intensively in recent years. Multiple research papers contribute to the current assessment. It is important to understand this: Not every study carries the same weight. Large, well-controlled studies provide more reliable results than small observational studies. The overall picture from these various studies is what we present to you here.
💡 What does this mean for you?
Risk should be presented as a spectrum, not as a binary warning. Talk with your dentist at your next visit about what this specifically means for your situation.
What is better: Treated or untreated periodontitis?
When it comes to treated versus untreated periodontitis, the research evidence is clearer than many people think. Here you will learn what current studies actually show.
The clinically crucial difference does not lie in the diagnosis of gum disease (periodontitis), but in the current periodontal status at the time of implant placement. Annunziata et al. (2025) show in subgroup analyses that patients with stages III to IV (severe) gum disease (periodontitis) have a higher risk for implant loss than patients with milder disease, and that implants with rough surfaces in periodontitis patients show an additionally increased loss risk.
Monje et al. (2014) emphasize that residual periodontal pockets serve as infection niches for implants and that disease-causing bacteria can still be detected in the gums surrounding compromised teeth even one year after extraction. The ecological conditions of the oral cavity directly influence biofilm formation on implants, which explains the mechanistic link between active gum disease (periodontitis) and periimplantitis risk.
The cost analysis by Ravidà et al. (2024) indirectly confirms the value of periodontal pretreatment: Patients with the lowest annual costs for periodontal therapy had the highest costs for tooth extractions and implant replacement, suggesting undertreatment. Conversely, invested periodontal therapy was cost-effective in non-smokers and former smokers in terms of avoiding implant need.
Bezerra et al. (2022) examined in a review of multiple studies the role of pro-inflammatory gene mutations in periimplantitis and included studies analyzing the relationship between genetic polymorphisms (particularly IL-1 and TNF-alpha variants) and periimplant diseases. Although a trend toward increased periimplantitis risk with certain polymorphisms was observed, the scientific evidence was heterogeneous and insufficient to recommend genetic testing as a clinical selection criterion.
Methodologically, it should be noted that the included studies varied considerably in study design, follow-up period, and population selection. This heterogeneity limits the comparability of results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For applicability to the German-speaking healthcare context, it is additionally relevant that a substantial portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structures, treatment practices, and patient access can influence effect sizes without making the basic conclusion invalid.
From this scientific evidence, the following follows for practice: The implant indication in people with gum disease depends not on the diagnosis alone, but on the current control status. Before implant planning, the periodontal findings must be completely assessed, active gum disease (periodontitis) must be treated, and a stable condition must be documented over at least three to six months.
Modifiable risk factors such as smoking and oral hygiene compliance must be addressed before implant placement, as they influence the prognosis more strongly than the historical diagnosis. Smoking cessation should be considered an integral part of implant planning in people with gum disease.
In everyday practice, this means: Scientific evidence does not provide a one-size-fits-all answer, but rather a framework for individualized decisions. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must be incorporated into the decision-making process.
What does this mean for you? The assessment should name the status precisely, not just the diagnosis.
What does this mean for your next dental visit? Research findings help you better understand your dentist's recommendations and ask specific questions if something is unclear.
``````htmlHow do scientists come to these conclusions? They don't just analyze a single study, but look at many investigations at the same time. This way, they can see whether a result was coincidental or whether it is confirmed again and again. In this case, the findings are based on 5 scientific papers from different countries and research groups.
💡 What does this mean for you?
Your dentist should clearly describe your specific condition, not just give you a diagnosis. Ask about what this means for your particular situation at your next dental visit.
What does "informed consent" mean for me as a patient?
One point that often causes uncertainty is informed consent. But science has made important progress in recent years.
Quantified risk increases allow for detailed patient counseling. Annunziata et al. (2025) provide the foundation for evidence-based risk assessment: With chronic gum disease (periodontitis) that is well-controlled and where patients follow treatment recommendations, the risk of implant loss is moderately higher than in people with healthy gums (HR 1.75). With previously aggressive or severe gum disease (periodontitis), the risk increases sixfold, which requires intensive follow-up care and more cautious decision-making about whether implants are appropriate.
Monje et al. (2014) measure bone loss at the edge of the implant as an additional way to predict outcomes: The average difference was -0.28 mm for aggressive periodontitis versus healthy people and -0.43 mm for aggressive periodontitis versus chronic periodontitis over an average period of 30 months. This accelerated bone loss is an early warning sign for implant problems and should be closely monitored during regular check-ups.
For patient discussions, it's important to know that the differences are real, but not dramatic, as long as gum disease is well-controlled. Annunziata et al. (2025) found no significant difference in early gum inflammation around implants between people with and without a history of periodontitis, which suggests that early signs of inflammation occur equally in both groups. Only when it progresses to severe implant-related inflammation does the risk difference become noticeable.
Smoking significantly increases the risk associated with gum disease. Ravidà et al. (2024) show in a dose-dependent way that heavy current smokers completely lose the benefit of gum disease treatment. For implant counseling, this means that the combination of a history of gum disease and active smoking is a particularly high-risk situation.
It's important to note that the studies included in this analysis differ considerably in their design, how long patients were followed up, and which types of patients were studied. This variation limits how much we can directly compare the results and explains why combined effect estimates must be interpreted with caution. However, the direction of the effect is consistent across different types of studies.
For applying these results to German-speaking dental care, it's also important that a significant portion of the scientific evidence comes from English-speaking or Scandinavian healthcare systems. Differences in how dental care is funded, treatment practices, and patient access can affect the size of the effects, but this doesn't make the main conclusion invalid.
Your dentist should clearly describe three risk levels: well-controlled chronic gum disease (periodontitis) (moderate additional risk), severe or rapidly worsening gum disease (periodontitis) (significantly increased risk), and active or uncontrolled gum disease (periodontitis) (implants not recommended until disease is stable). Changeable factors like quitting smoking and following treatment recommendations should be discussed as ways to improve outcomes.
Follow-up care for people with gum disease who have implants should be more frequent than for people with healthy gums. Check-up visits every three to six months with systematic measurement of pocket depth, bleeding when probed, and X-rays to check bone level are recommended.
In everyday dental practice, this means: The scientific evidence doesn't provide one-size-fits-all answers, but rather a framework for individualized decisions. Patient-specific factors such as overall health, likelihood of following recommendations, individual risk profiles, and treatment preferences must be considered in the decision.
What does this mean for you? Your dentist should discuss risk factors that you can influence.
What does this mean for your next dental visit? These research findings help you better understand your dentist's recommendations and ask specific questions if something is unclear.
What makes these results reliable? In medical research: The more independent studies that reach the same conclusion, the more confident we can be. The type of study and number of participants also matter. Large controlled studies with many participants provide more reliable results than small surveys.
💡 What does this mean for you?
Your dentist should discuss risk factors that you can influence. Ask what this specifically means for your situation at your next dental visit.
Frequently asked questions
Here we answer the questions patients ask most often about this topic:
❓ What does "quantifying additional risk" mean for me as a patient?
Patients with treated gum disease (periodontitis) have an increased but not prohibitive risk. The risk should be presented as a spectrum, not as a simple yes-or-no warning.
❓ What is better: treated or untreated gum disease?
Successfully treated gum disease (periodontitis) significantly lowers implant risk compared to uncontrolled disease. Your dentist should clearly describe your specific condition, not just give you a diagnosis.
❓ What does "informed consent" mean for me as a patient?
Informed consent requires a quantified risk statement. Your dentist should discuss risk factors that you can influence.
❓ How reliable are these results?
The scientific basis is solid, but not all questions have been fully answered.
❓ Should I change my behavior based on this information?
Talk with your dentist before making any changes. This article informs you about the current state of research, but every situation is individual. Your dentist knows your personal health situation best.
❓ Where can I learn more?
You can find the detailed professional version of this article with all study details on Daily Dental Journal. For personal advice, please consult your dentist.
❓ What is the key message of this article?
A history of gum disease (periodontitis) increases the risk, but does not rule out dental implants.
❓ Why are there different opinions on this topic?
The conflict lies between pessimistic predictions and the clinical reality that many people with gum disease can be successfully treated with implants.
🦷 When should you see a dentist?
Schedule an appointment with your dentist if:
- You are unsure whether a recommended treatment makes sense for you
- You have symptoms or notice changes
- You would like a second opinion
- You have questions about the topics described in this article
- Your last dental visit was more than a year ago
Important: This article is not a substitute for a dental visit. It helps you have an informed conversation with your dentist.
What you can do yourself
Here are concrete steps you as a patient can take:
The bottom line
It's not the gum disease (periodontitis) diagnosis alone that determines your implant risk, but whether it is controlled and whether you actively participate in your care.
Continuing education
DDJ Continuing Education
Continuing Education Unit
Knowledge Check: How much does a history of periodontitis increase the risk for P
Test your knowledge: How much does a history of periodontitis increase the risk for peri-implantitis and implant loss, and what does this mean for patient selection?
Learning objectives
What you should know after completing this module
- You understand the key research findings on this topic.
- You know the limitations of current research.
- You know what questions to ask your dentist.
- You understand what "understanding your increased risk" means for your dental health.
- You understand what "treated vs. untreated periodontitis" means for your dental health.
Conflicts of interest
Transparency first
- Author information: DDJ editorial expert text, no sponsor mentioned in the text.
- Reviewer: Internal DDJ expert editorial board for pilot operation.
- Limitation: Pilot module without official professional board recognition; points serve as DDJ test logic.
Continuing education status: 3 attempts remaining. To pass, you need 7 out of 10 correct answers.
About this article's sources
This article is based on current scientific evidence and editorial review. All statements are supported by studies and presented in a way that is easy for patients to understand.
The content has been prepared by our editorial team for patients. Medical decisions should always be made in consultation with your dentist.
Last updated: March 2026 · Language: English · Audience: Patients and interested individuals